Testing IN026 for Hard-to-Treat Gout
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study tests a new drug called IN026 for people with refractory gout—gout that doesn't respond well to current treatments and causes severe symptoms. The goal is to see if IN026 can lower uric acid levels and reduce gout attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have gout that is difficult to control (high uric acid levels and severe symptoms despite treatment)
- Your gout must be confirmed by 2015 ACR/EULAR criteria, and you must not be having an active gout attack (or it must have resolved at least 2 weeks ago)
- Your serum uric acid level must be at least 420 μmol/L (7 mg/dL) at screening
- You must be between 18 and 75 years old
- You cannot have certain infections (hepatitis B, hepatitis C without successful treatment, HIV, or active syphilis)
- You must not have taken other urate-lowering drugs, uricase agents, or certain vaccines in the required timeframe before enrollment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether applying heat (thermotherapy) can help people with difficult-to-treat gout. It aims to reduce gout attacks and improve symptoms.
This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.
This study tests a medicine called SSGJ-613 to see if it can reduce gout flares when people start treatment to lower uric acid. It may help people who have frequent gout attacks.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.
This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.
Hear when a new Refractory Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.